GSDMD and infection: Based on the above deduction, we observed whether the inhibitor of GSDMD, NSA, could reduce the release of TNF-α and prevent the reduction of NK cell depletion to enhance the body’s ability to resist infections and to alleviate the lung tissue damage induced by PRV infection.